Overview

An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

Status:
Recruiting
Trial end date:
2023-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Interferon-beta
Interferons